Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lodge

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
Journal of Medicinal Chemistry|May 24, 1996
Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitutionP L Ornstein, M B Arnold, N K Allen, et al.
British Journal of Pharmacology|September 19, 2000
A novel, competitive mGlu(5) receptor antagonist (LY344545) blocks DHPG-induced potentiation of NMDA responses but not the induction of LTP in rat hippocampal slicesA J Doherty, M J Palmer, Z A Bortolotto, et al.
Journal of Medicinal Chemistry|May 24, 1996
Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activityP L Ornstein, M B Arnold, N K Allen, et al.
Neuropharmacology|January 14, 1999
The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticityS M Fitzjohn, Z A Bortolotto, M J Palmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1998
Human autoantibodies specific for the alpha1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neuronsA Pinto, S Gillard, F Moss, et al.
Journal of Medicinal Chemistry|September 18, 1992
6-substituted decahydroisoquinoline-3-carboxylic acids as potent and selective conformationally constrained NMDA receptor antagonistsP L Ornstein, D D Schoepp, M B Arnold, et al.
Annals of the New York Academy of Sciences|February 11, 2000
Neuroprotective actions of novel and potent ligands of group I and group II metabotropic glutamate receptorsA E Kingston, M J O'Neill, A Bond, et al.
Journal of Medicinal Chemistry|September 4, 1992
Synthesis and excitatory amino acid pharmacology of a series of heterocyclic-fused quinoxalinones and quinazolinonesL A McQuaid, E C Smith, K K South, et al.
Neuropharmacology|January 1, 1996
Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profilesD Bleakman, B A Ballyk, D D Schoepp, et al.
Neuroscience|April 1, 1996
Distribution of alpha 1A, alpha 1B and alpha 1E voltage-dependent calcium channel subunits in the human hippocampus and parahippocampal gyrusN C Day, P J Shaw, A L McCormack, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Journal of Medicinal Chemistry|May 24, 1996
Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitutionP L Ornstein, M B Arnold, N K Allen, et al.
British Journal of Pharmacology|September 19, 2000
A novel, competitive mGlu(5) receptor antagonist (LY344545) blocks DHPG-induced potentiation of NMDA responses but not the induction of LTP in rat hippocampal slicesA J Doherty, M J Palmer, Z A Bortolotto, et al.
Journal of Medicinal Chemistry|May 24, 1996
Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activityP L Ornstein, M B Arnold, N K Allen, et al.
Neuropharmacology|January 14, 1999
The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticityS M Fitzjohn, Z A Bortolotto, M J Palmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1998
Human autoantibodies specific for the alpha1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neuronsA Pinto, S Gillard, F Moss, et al.
Journal of Medicinal Chemistry|September 18, 1992
6-substituted decahydroisoquinoline-3-carboxylic acids as potent and selective conformationally constrained NMDA receptor antagonistsP L Ornstein, D D Schoepp, M B Arnold, et al.
Annals of the New York Academy of Sciences|February 11, 2000
Neuroprotective actions of novel and potent ligands of group I and group II metabotropic glutamate receptorsA E Kingston, M J O'Neill, A Bond, et al.
Journal of Medicinal Chemistry|September 4, 1992
Synthesis and excitatory amino acid pharmacology of a series of heterocyclic-fused quinoxalinones and quinazolinonesL A McQuaid, E C Smith, K K South, et al.
Neuropharmacology|January 1, 1996
Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profilesD Bleakman, B A Ballyk, D D Schoepp, et al.
Neuroscience|April 1, 1996
Distribution of alpha 1A, alpha 1B and alpha 1E voltage-dependent calcium channel subunits in the human hippocampus and parahippocampal gyrusN C Day, P J Shaw, A L McCormack, et al.
Pageof 14